Exelixis, Inc.
EXEL NASDAQHealthcare ★★★★★Latest Earnings
Date
Aug 5, 2026
ET
EPS Est.
0.85
EPS Actual
0.91
Revenue Est.
$636.4M
Revenue Actual
$628.7M
Next Earnings Report
Date
Nov 3, 2026 · Tue
Time
After-market
Fiscal Period
FY2026 Q3
EPS Est.
0.89
Revenue Est.
$650.3M
Company Overview
Exelixis, Inc. (ticker EXEL) is listed on NASDAQ with a market cap of about $13.59B. Its next earnings report (FY2026 Q3) is expected on Nov 3, 2026 (ET), After-market, with consensus EPS of 0.89. In the last 15 reported quarters, EPS beat consensus estimates 12 times.
Actual EPS TrendRecently15Term · Feb 7, 2023 → Aug 5, 2026
Feb 7, 2023Range: -0.09 ~ 0.94Aug 5, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 5, 2026 | -- | 0.85 | 0.91 | $636.4M | $628.7M |
| May 5, 2026 | -- | 0.77 | 0.87 | $607.5M | $610.8M |
| Feb 10, 2026 | -- | 0.77 | Above forecast↑0.94 | $596.5M | $598.7M |
| Nov 4, 2025 | -- | 0.69 | 0.78 | $590.2M | $597.8M |
| Jul 28, 2025 | -- | 0.65 | Above forecast↑0.75 | $594.9M | $568.3M |
| May 13, 2025 | -- | 0.36 | Above forecast↑0.62 | $499.6M | $555.4M |
| Feb 11, 2025 | -- | 0.51 | 0.55 | $563.2M | $566.8M |
| Oct 29, 2024 | -- | 0.35 | 0.40 | $556.6M | $539.5M |
| Aug 6, 2024 | -- | 0.30 | Above forecast↑0.77 | $465M | $637.2M |
| Apr 30, 2024 | -- | 0.28 | Below forecast↓0.17 | $460.6M | $425.2M |
| Feb 6, 2024 | -- | 0.21 | Above forecast↑0.27 | $480.2M | $479.7M |
| Nov 1, 2023 | -- | 0.10 | 0.10 | $471.9M | $471.9M |
| Aug 1, 2023 | -- | 0.16 | Above forecast↑0.25 | $447.6M | $469.8M |
| May 9, 2023 | -- | 0.15 | Below forecast↓0.12 | $424.1M | $408.8M |
| Feb 7, 2023 | -- | -0.11 | Above forecast↑-0.09 | $417.6M | $423.9M |
Original Filings (SEC)
10-Q2026-08-05 ↗
8-K2026-08-05 ↗
8-K2026-05-29 ↗
10-Q2026-05-05 ↗
8-K2026-05-05 ↗
10-K2026-02-10 ↗
8-K2026-02-10 ↗
8-K2026-01-12 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
